Manufacture

We interview Vetter’s Thomas Otto about his career and the importance of sustainability in the pharma industry.

Gene therapy can help millions of patients with rare diseases, but one hurdle is preventing the field from achieving liftoff.

Changes are coming to Annex 1 of the EU’s GMP. What can pharma expect?

Building and managing an advanced therapy collection network is a significant challenge, but there is another route.

Implementing Industry 4.0 concepts for the best manufacturing outcomes.

While you’re busy scaling up your bioprocesses, don’t forget about the secure supply of all critical raw materials

To keep biosimilars costs as low as possible, take a good look at your purification and characterization processes.

Experts explain how cell therapies can tackle tumors in our 2021 supplement on cell and gene therapies.

How can we improve transdermal packaging options for the Indian pharmaceutical market?

Meet two companies whose technologies are helping to advance drug development and manufacturing.